Monday 31 March 2014 1:05pm
Dr Anita Dunbier's study targeting the immune response to anti-oestrogen therapy is among three newly funded innovative research projects which share the goal of improving and ultimately ensuring breast cancer survival in New Zealand.
Read more about her work:
- Innovative Otago breast cancer research gains support University of Otago media release
- Targeting the immune response to improve outcomes in ER+ve breast cancer Health Research Council website
- Breast cancer: Novel genes involved in susceptibility and response
- How do immune cells help breast cancers to evade therapy?
